[论文解读] COVID-19: Should We Test Everyone?

Grace Y. Yi, Wenqing He+2 more|arXiv (Cornell University)|Apr 2, 2020

COVID-19 diagnosis using AI参考文献 5被引用 6

一句话总结

本文评估了大规模新冠检测的统计影响，强调必须将检测不准确性（尤其是假阴性和假阳性）纳入检测决策考量。研究主张应进行重复检测，并根据患者健康状况对检测性能进行分层评估，以优化有限资源并提高检测准确性。

ABSTRACT

Since the beginning of 2020, the coronavirus disease 2019 (COVID-19) has spread rapidly in the city of Wuhan, P.R. China, and subsequently, across the world. The swift spread of the virus is largely attributed to its stealth transmissions in which infected patients may be asymptomatic. Undetected transmissions present a remarkable challenge for the containment of the virus and pose an appalling threat to the public. An urgent question that has been asked by the public is "Should I be tested for COVID-19 if I am sick?". While different regions established their own criteria for screening infected cases, the screening criteria have been modified based on new evidence and understanding of the virus as well as the availability of resources. The shortage of test kits and medical personnel has considerably limited our ability to do as many tests as possible. Public health officials and clinicians are facing a dilemma of balancing the limited resources and unlimited demands. On one hand, they are striving to achieve the best outcome by optimizing the usage of the scant resources. On the other hand, they are challenged by the patients' frustrations and anxieties, stemming from the concerns of not being tested for COVID-19 for not meeting the definition of PUI (person under investigation). In this paper, we evaluate the situation from the statistical viewpoint by factoring into the considerations of the uncertainty and inaccuracy of the test, an issue that is often overlooked by the general public. We aim to shed light on the tough situation by providing evidence-based reasoning from the statistical angle, and we expect this examination will help the general public understand and assess the situation rationally. Most importantly, the development offers recommendations for physicians to make sensible evaluations to optimally use the limited resources for the best medical outcome.

研究动机与目标

• 解决在检测资源有限的情况下，公众和临床领域关于谁应接受新冠检测的困境。
• 量化检测不准确性（特别是假阴性和假阳性）对检测结果的影响。
• 提供基于证据的统计推理，以指导医疗人员在资源受限条件下优化检测使用。
• 建议根据患者亚组（如年龄、症状、共病）而非整体敏感性和特异性，对检测性能进行精细化评估。
• 探讨重复检测以及替代诊断工具（如CT扫描、快速分子检测）在提高检测准确性方面的作用。

提出的方法

• 使用统计建模方法评估检测敏感性和特异性对个体和群体检测结果的影响。
• 基于报告的敏感性和特异性数值，比较两种真实世界检测方法——Hutchison（2020）的RT-PCR检测和IgM-IgG快速检测。
• 分析重复检测对降低假阴性率的影响，假设检测结果相互独立。
• 提出对感染状态 $Y(t)$ 进行时间依赖性建模，以反映感染概率随时间的动态变化。
• 建议根据患者特征（如症状严重程度、共病情况）对检测性能指标进行分层，以改善临床决策。
• 评估在分层检测策略中整合CT扫描和快速分子检测（如Cepheid的Xpert Xpress）等替代筛查工具的效果。

实验结果

研究问题

• RQ1 检测不准确性（尤其是假阴性）如何影响个体和群体检测结果的可靠性？
• RQ2 如何制定最优的重复检测策略，在节约资源的同时最小化漏诊？
• RQ3 如何在不同患者亚组中更优地评估检测性能，而非仅依赖单一的整体敏感性和特异性？
• RQ4 当RT-PCR结果不明确时，替代诊断工具（如CT扫描、快速分子检测）在提高检测准确性方面发挥什么作用？
• RQ5 检测方案应如何随时间调整，以反映流行病学状况的变化和公共卫生措施的演变？

主要发现

• 新冠IgM-IgG快速检测的敏感性和特异性高于Hutchison（2020）报告的检测方法，但因患者队列和样本量不同，该比较存在局限性。
• 重复检测可显著降低假阴性结果的概率，随时间推移提高对感染个体的检出率。
• 对感染状态 $Y(t)$ 进行时间依赖性建模对于反映病毒载量和传播风险的动态变化至关重要。
• 迫切需要按不同患者亚组（如症状严重程度、共病情况）分别报告检测性能指标（敏感性和特异性）。
• CT扫描和快速分子检测（如Cepheid的Xpert Xpress）等替代工具可作为筛查中的宝贵补充，尤其适用于RT-PCR结果为阴性的患者。
• 采用分层检测策略——即使用快速但准确度较低的检测进行初步筛查，再用更准确但成本更高的检测进行确认——可优化资源使用并提高检测效率。